The Gross Law Firm Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 – HIMS

Core Viewpoint - Hims & Hers Health, Inc. is facing a class action lawsuit due to allegations of misleading statements and deceptive practices related to the promotion of illegitimate products, which may jeopardize its collaboration with Novo Nordisk [3][4]. Summary by Relevant Sections Allegations - The complaint claims that during the class period from April 29, 2025, to June 23, 2025, Hims engaged in deceptive promotion and selling of illegitimate versions of Wegovy®, risking patient safety [3]. - It is alleged that this conduct created a substantial risk of termination of the company's collaboration with Novo Nordisk [3]. - The defendants' positive statements regarding the company's business and prospects were deemed materially misleading and lacked a reasonable basis due to these issues [3]. Class Action Details - Shareholders who purchased HIMS shares during the specified class period are encouraged to register for the class action, with a deadline set for August 25, 2025 [4]. - Participants will be enrolled in a portfolio monitoring system to receive updates on the case's progress [4]. - There is no cost or obligation for shareholders to participate in this class action [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].